Last Updated: November 9, 2026

Patent: 9,212,357

Summary for Patent: 9,212,357

Title:	Thrombin solution and methods of use thereof
Abstract:	Provided are methods for lyophilization of an aqueous thrombin solution, thrombin solutions for use in such lyophilization methods, and solid thrombin compositions produced by such methods.
Inventor(s):	Roberto Meidler, Oleg Belyaev, Liliana Bar, Israel Nur
Assignee:	Omrix Biopharmaceuticals Ltd
Application Number:	US13/783,592
Patent Claims:	see list of patent claims

Details for Patent 9,212,357

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Omrix Biopharmaceuticals Ltd	EVITHROM	thrombin, topical (human)	Solution	125247	August 27, 2007	9,212,357	2033-03-04
Omrix Biopharmaceuticals Ltd	EVITHROM	thrombin, topical (human)	For Injection	125247	September 17, 2009	9,212,357	2033-03-04
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,212,357

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2013353636	⤷ Start Trial
Brazil	112015013071	⤷ Start Trial
Brazil	122022012099	⤷ Start Trial
Canada	2892083	⤷ Start Trial
China	104822387	⤷ Start Trial
China	110251468	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.